Edward Chu was named director of Albert Einstein Cancer Center, vice president for cancer medicine at Montefiore Medicine, professor of medicine and of molecular pharmacology, and will hold the Carol and Roger Einiger Professorship of Cancer Medicine at Einstein.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
